Stockscreener 앱 받기
9.20
2.34%
0.21
시간 외 거래:
9.31
0.11
+1.20%
전일 마감가:
$8.99
열려 있는:
$9
하루 거래량:
166.71K
Relative Volume:
0.53
시가총액:
$202.43M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-9.7872
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
+6.60%
1개월 성능:
+32.37%
6개월 성능:
+78.29%
1년 성능:
+233.33%
1일 변동 폭
$8.835
$9.21
1주일 범위
$8.48
$9.21
52주 변동 폭
$2.38
$9.21
Exagen Inc Stock (XGN) Company Profile
명칭
Exagen Inc
전화
(760) 560-1501
주소
1261 LIBERTY WAY, VISTA, CA
XGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
9.20 | 196.05M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | 개시 | Craig Hallum | Buy |
| 2022-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-04-15 | 개시 | Canaccord Genuity | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cowen | Outperform |
| 2019-10-14 | 개시 | William Blair | Outperform |
모두보기
Exagen Inc 주식(XGN)의 최신 뉴스
Exagen Inc. Recovery Gathers Momentum on Chart SignalsAI Based High Gain Watchlist Scanner Shared - beatles.ru
Is Exagen Inc. reversing from oversold territorySafe Entry Zone Based on Chart Analysis - Newser
What makes Exagen Inc. stock price move sharplyBreakout Screener With Alert Based Timing - Newser
What’s next for Exagen Inc. stock priceReversal Signal Prediction Based on Volume - Newser
Building trade automation scripts for Exagen Inc.Free ROI Boosting Trade Opportunity Calendar - Newser
Applying big data sentiment scoring on Exagen Inc.Weekly Entry Signal Based Forecast Tool - Newser
Exagen Inc. to Participate in Third Quarter Investor Conferences - The Manila Times
Exagen Doubles Down on Investor Outreach: Set for Major Healthcare Conference Circuit - Stock Titan
Exagen Inc.'s (NASDAQ:XGN) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - simplywall.st
What drives Exagen Inc. stock priceFree Stock Market Beginners Guide - Jammu Links News
What are the latest earnings results for Exagen Inc.Discover breakthrough trading strategies - Jammu Links News
Is Exagen Inc. a good long term investmentMaximize your gains with expert trading tips - Jammu Links News
What are Exagen Inc. company’s key revenue driversBreakthrough financial growth - Jammu Links News
What are analysts’ price targets for Exagen Inc. in the next 12 monthsSuperior returns - Jammu Links News
What is the risk reward ratio of investing in Exagen Inc. stockBreakthrough profit margins - Jammu Links News
What catalysts could drive Exagen Inc. stock higher in 2025Build wealth steadily with smart stock selection - Jammu Links News
Is Exagen Inc. a growth stock or a value stockInvest smarter with advanced market data - Jammu Links News
Is Exagen Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - Jammu Links News
Is it the right time to buy Exagen Inc. stockRemarkably fast returns - Jammu Links News
What is the dividend policy of Exagen Inc. stockUnmatched profit potential - Jammu Links News
Exagen outlines $65M–$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline - MSN
Exagen Inc. (NASDAQ:XGN) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Exagen Inc. stock outlook for YEARStock Performance Summary Over One Year - Newser
Exagen Inc. Reports Record Revenue Amidst Growth Challenges - The Globe and Mail
What markets is Exagen Inc. expanding into Is LILA stock a good long term investment optionExpert Picks Data Feed For Consistent Profits - Jammu Links News
Personalized Medicine Market Future Business Opportunities - openPR.com
What risks could impact Exagen Inc. stock performanceDaily Upside Movement Prediction With Data - Newser
Exagen Analyst Ratings: Bullish Sentiment Dominates - AInvest
Exagen's Q2 Growth Validates Buy Rating, Analyst Says - AInvest
Exagen price target raised to $11 from $8 at Canaccord - TipRanks
Exagen price target raised to $10 from $7 at Cantor Fitzgerald - TipRanks
Canaccord Genuity Sticks to Its Buy Rating for Exagen (XGN) - The Globe and Mail
Exagen stock price target raised to $10 from $7 at Cantor Fitzgerald - Investing.com Nigeria
Exagen stock price target raised to $10 from $7 at Cantor Fitzgerald By Investing.com - Investing.com South Africa
KeyBanc upgrades Exagen on improved revenue visibility - TipRanks
Visual analytics tools that track Exagen Inc. performanceLow Risk Stock Selection Strategy Guide - Newser
KeyBanc upgrades Exagen stock to Overweight on improved pricing and growth - Investing.com Nigeria
Chart based analysis of Exagen Inc. trendsTop Stock Picks with Forecast Accuracy - Newser
Key metrics from Exagen Inc.’s quarterly dataHigh Probability Trade Outcome Prediction - Newser
Why Exagen Inc. stock attracts strong analyst attentionLow Risk Stock Selection Strategy Guide - Newser
Exagen Reports Record Q2 2025 Revenue of $17.2M, Announces Strategic Updates - AInvest
Exagen Inc. Reports Record Q2 2025 Revenue - TipRanks
Exagen 2025 Q2 Earnings Misses Targets as Net Loss Widens 49.7% - AInvest
Exagen Q2 Revenue Jumps 14 Percent - AOL.com
Exagen Inc (XGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):